rs368507578

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001358921.2(COQ2):​c.189G>T​(p.Val63Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00124 in 1,553,630 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0065 ( 11 hom., cov: 34)
Exomes 𝑓: 0.00066 ( 6 hom. )

Consequence

COQ2
NM_001358921.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -4.63

Publications

2 publications found
Variant links:
Genes affected
COQ2 (HGNC:25223): (coenzyme Q2, polyprenyltransferase) This gene encodes an enzyme that functions in the final steps in the biosynthesis of CoQ (ubiquinone), a redox carrier in the mitochondrial respiratory chain and a lipid-soluble antioxidant. This enzyme, which is part of the coenzyme Q10 pathway, catalyzes the prenylation of parahydroxybenzoate with an all-trans polyprenyl group. Mutations in this gene cause coenzyme Q10 deficiency, a mitochondrial encephalomyopathy, and also COQ2 nephropathy, an inherited form of mitochondriopathy with primary renal involvement. [provided by RefSeq, Oct 2009]
COQ2 Gene-Disease associations (from GenCC):
  • coenzyme Q10 deficiency, primary, 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • multiple system atrophy
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • Leigh syndrome with nephrotic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 4-83284576-C-A is Benign according to our data. Variant chr4-83284576-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 136980.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.63 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00652 (992/152178) while in subpopulation AFR AF = 0.0224 (929/41552). AF 95% confidence interval is 0.0212. There are 11 homozygotes in GnomAd4. There are 466 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COQ2NM_001358921.2 linkc.189G>T p.Val63Val synonymous_variant Exon 1 of 7 ENST00000647002.2 NP_001345850.1
COQ2NM_015697.9 linkc.339G>T p.Val113Val synonymous_variant Exon 1 of 7 NP_056512.5 Q96H96-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COQ2ENST00000647002.2 linkc.189G>T p.Val63Val synonymous_variant Exon 1 of 7 NM_001358921.2 ENSP00000495761.2 Q96H96-1
COQ2ENST00000311469.9 linkc.339G>T p.Val113Val synonymous_variant Exon 1 of 7 1 ENSP00000310873.4 Q96H96-4
COQ2ENST00000311461.7 linkc.189G>T p.Val63Val synonymous_variant Exon 1 of 7 5 ENSP00000311835.7 Q96H96-3E2QRG7
COQ2ENST00000503391.5 linkn.189G>T non_coding_transcript_exon_variant Exon 1 of 7 2 ENSP00000426242.1 E7EPM7

Frequencies

GnomAD3 genomes
AF:
0.00652
AC:
992
AN:
152066
Hom.:
11
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0224
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00575
GnomAD2 exomes
AF:
0.00109
AC:
159
AN:
145330
AF XY:
0.000813
show subpopulations
Gnomad AFR exome
AF:
0.0231
Gnomad AMR exome
AF:
0.00108
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000218
Gnomad OTH exome
AF:
0.00100
GnomAD4 exome
AF:
0.000664
AC:
930
AN:
1401452
Hom.:
6
Cov.:
84
AF XY:
0.000603
AC XY:
418
AN XY:
692790
show subpopulations
African (AFR)
AF:
0.0221
AC:
668
AN:
30160
American (AMR)
AF:
0.00147
AC:
54
AN:
36710
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24870
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35138
South Asian (SAS)
AF:
0.0000377
AC:
3
AN:
79536
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48210
Middle Eastern (MID)
AF:
0.00182
AC:
10
AN:
5506
European-Non Finnish (NFE)
AF:
0.000110
AC:
119
AN:
1083278
Other (OTH)
AF:
0.00131
AC:
76
AN:
58044
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
57
114
172
229
286
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00652
AC:
992
AN:
152178
Hom.:
11
Cov.:
34
AF XY:
0.00626
AC XY:
466
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.0224
AC:
929
AN:
41552
American (AMR)
AF:
0.00262
AC:
40
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10596
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
67966
Other (OTH)
AF:
0.00569
AC:
12
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
57
114
171
228
285
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000472
Hom.:
0
Bravo
AF:
0.00766

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 28, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Focal segmental glomerulosclerosis Benign:1
Jul 13, 2020
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
0.13
DANN
Benign
0.65
PhyloP100
-4.6
PromoterAI
-0.11
Neutral
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs368507578; hg19: chr4-84205729; API